Red urinary discolouration following hydroxocobalamin treatment for vasoplegic syndrome

Canadian Journal of Anesthesia

Volumn 64, Issue 6, 2017, Pages 673-674

  Warner, Matthew A ^a   Mauermann, William J ^a   Armour, Sarah ^a   Barbara, David W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPINEPHRINE; HYDROXOCOBALAMIN; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN; VITAMIN B COMPLEX;

ABDOMINAL AORTIC STENT GRAF; AGED; ARTICLE; CASE REPORT; CHROMATURIA; DRUG MEGADOSE; DRUG SAFETY; HEMODYNAMICS; HUMAN; INTRAOPERATIVE PERIOD; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RED URINARY DISCOLOURATION; STENT GRAFT; URINALYSIS; URINARY TRACT DISEASE; URINE COLOR; VASOPLEGIA; VERY ELDERLY; CHEMISTRY; COLOR; URINE;

AGED, 80 AND OVER; COLOR; HUMANS; HYDROXOCOBALAMIN; MALE; URINE; VASOPLEGIA; VITAMIN B COMPLEX;

EID: 85013428291     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-017-0849-5     Document Type: Article

References (5)

1. Roderique JD, VanDyck K, Holman B, Tang D, Chui B, Spiess BD. The use of high-dose hydroxocobalamin for vasoplegic syndrome. Ann Thorac Surg 2014; 97: 1785-6.
2. Geraci MJ, McCoy SL, Aquino ME. Woman with red urine: hydroxocobalamin-induced chromaturia. J Emerg Med 2012; 43: e207-9.
3. Raymond JR, Yarger WE. Abnormal urine color: differential diagnosis. South Med J 1988; 81: 837-41.
4. Stellpflug SJ, Gardner RL, Leroy JM, Ellsworth H, Zwank MD. Hydroxocobalamin hinders hemodialysis. Am J Kidney Dis 2013; 62: 395.
5. Pamidi PV, DeAbreu M, Kim D, Mansouri S. Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta 2009; 401: 63-7.